Niagen Bioscience, Inc.
NAGENext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for NAGE. That does not mean none is planned.
Get an email about NAGE's next catalysts
Track Niagen Bioscience (NAGE) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Niagen Bioscience (NASDAQ: NAGE), formerly ChromaDex, is a bioscience Ρompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.
WebsiteNo drugs found in this phase.
Frequently asked questions
When is Niagen Bioscience, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Niagen Bioscience, Inc. (NAGE) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track NAGE biotech catalysts?β
Add NAGE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Niagen Bioscience, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.